Myoview (Tetrofosmin)

Tetrofosmin is a lipophilic cation that, when labeled with technetium‑99m, is taken up by myocardial cells proportionally to regional blood flow. The emitted gamma photons are captured by SPECT cameras, producing images that reflect perfusion patterns across the heart.

The dose of Myoview is determined by the prescribing physician based on the specific imaging protocol, patient weight, and the type of stress test being performed. Dosage details are provided in the product labeling and should not be altered without medical guidance.

Safety of Myoview in pregnancy and lactation has not been established. It should only be used if the potential diagnostic benefit outweighs the possible risk to the fetus or infant, and after a thorough risk assessment by the healthcare provider.

To order Myoview, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain where applicable) and necessary import documentation.

Myoview (technetium‑99m tetrofosmin) offers rapid myocardial uptake and clear imaging quality comparable to other technetium‑99m agents such as sestamibi. It has a similar safety profile, but differences in biodistribution and imaging timing may influence protocol selection based on institutional preference.

Myoview should be stored at ambient temperature, protected from light and moisture, and kept in its original packaging until use. Do not freeze the solution, and follow local regulations for handling radiopharmaceuticals to maintain stability and safety.

Myoview is administered intravenously as a sterile solution for injection. The radiotracer is injected under controlled conditions, typically shortly before or after a cardiac stress maneuver, and imaging is performed according to the prescribed MPI protocol.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, marked hypotension, and cardiac arrhythmias. Immediate medical attention is required if any signs of these reactions appear during or after the injection.

Myoview should be avoided in patients with known hypersensitivity to tetrofosmin, technetium‑99m, or any component of the formulation. Caution is also advised for individuals with severe renal impairment or uncontrolled cardiac conditions where stress testing is contraindicated.